-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CGylNsPkAeNGicsmYtoocXNnLYgDWYNz22o3JcCAqeJ0ln2g2ILEd/FMvMgTUcV0 KwiMwyAuZvBfccNiQy6TjA== 0000950168-01-000215.txt : 20010213 0000950168-01-000215.hdr.sgml : 20010213 ACCESSION NUMBER: 0000950168-01-000215 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-48083 FILM NUMBER: 1533216 BUSINESS ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ESHELMAN FREDRIC N CENTRAL INDEX KEY: 0001033409 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: PPD INC STREET 2: 3151 17TH STREET EXTENSION CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: PPD INC STREET 2: 3151 17TH STREET EXTENSION CITY: WILMINGTON STATE: NC ZIP: 28412 SC 13G 1 0001.txt SC 13G-FREDRIC N. ESHELMAN Page 1 SCHEDULE 13G Name of Issuer: Pharmaceutical Product Development, Inc. Title of Class of Securities: Common Stock CUSIP Number: 717124101 (1) Names of reporting Persons. S.S. or IRS. Identification Nos. of Above Persons. Fredric N. Eshelman (2) Check the Appropriate Box if a Member of a Group: NOT APPLICABLE (a) (b) (3) SEC Use Only: (4) Citizenship or Place of Organization: United States Number of Shares Beneficially Owned : (5) Sole Voting Power: 3,034,444 (6) Shared Voting Power: 0 (7) Sole Dispositive Power: 3,034,444 (8) Shared Dispositive Power: 0 (9) Aggregate Amount Beneficially Owned by Each Reporting Person: 3,034,444 (10) Check if the Aggregate amount in Row (9) Excludes Certain Shares: Not Applicable (11) Percent of Class Represented by Amount in Row (9): 12.0% (12) Type of Reporting Person: IN Page 2 Item 1 Issuer (a) Pharmaceutical Product Development, Inc. (b) 3151 South 17th Street Wilmington, North Carolina 28412 Item 2. Person Filing (a) Fredric N. Eshelman (b) Pharmaceutical Product Development, Inc. 3151 South 17th Street Wilmington, North Carolina 28412 (c) United States (d) Common Stock (e) 717124101 Item 3. Filing Pursuant to Rules 13d-1(b) or 13(d)-2(b) Not Applicable Item 4. Ownership (a) 3,034,444 includes 66,666 shares issuable pursuant to vested options. (b) 12.0% (c) The Reporting Person retains sole voting and dispositive power of all shares. Item 5. Ownership of Five Percent or Less of Class Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not Applicable Item 8. Identification and Classification of Members of the Group Not Applicable Item 9. Notice of Dissolution of Group Not Applicable Item 10. Certification Not Applicable Page 3 After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 12, 2001 - ------------------- Date Fredric N. Eshelman /s/ Fredric N. Eshelman -----END PRIVACY-ENHANCED MESSAGE-----